{
  "ticker": "TNYA",
  "company_name": "Tenaya Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06228924",
      "title": "Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "start_date": "2024-03-26",
      "completion_date": "2029-10-01",
      "enrollment": 0,
      "sponsor": "Tenaya Therapeutics"
    },
    {
      "nct_id": "NCT05112237",
      "title": "Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Cardiomyopathy",
      "start_date": "2021-11-01",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "Tenaya Therapeutics"
    },
    {
      "nct_id": "NCT06311708",
      "title": "Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "start_date": "2023-01-31",
      "completion_date": "2030-07-11",
      "enrollment": 0,
      "sponsor": "Tenaya Therapeutics"
    },
    {
      "nct_id": "NCT05836259",
      "title": "Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Hypertrophic Cardiomyopathy",
      "start_date": "2023-08-10",
      "completion_date": "2032-08",
      "enrollment": 0,
      "sponsor": "Tenaya Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 4,
    "by_phase": {
      "PHASE1": 1,
      "": 2,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 4
    },
    "active_trials": 4,
    "completed_trials": 0,
    "conditions": [
      "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "Cardiomyopathy",
      "Hypertrophic Cardiomyopathy"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:27.620084",
    "search_query": "Tenaya Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Tenaya+Therapeutics,+Inc."
  }
}